​

Processa Pharmaceuticals Ownership | Who Owns Processa Pharmaceuticals?

OverviewForecastFinancialsChart

Processa Pharmaceuticals Ownership Summary

Processa Pharmaceuticals is owned by 4.19% institutional investors, and 95.81% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.75% of its assets in Processa Pharmaceuticals shares.

PCSA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockProcessa Pharmaceuticals4.19%-95.81%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202318-10.00%1,130,700-18.42%415.81%10-9.09%525.00%
Sep 30, 20232011.11%1,386,038-0.25%513.82%11120.00%4-42.86%
Jun 30, 202318-18.18%1,389,520-15.80%611.62%5-58.33%7133.33%
Mar 31, 20232222.22%1,650,24542.14%712.62%1233.33%3200.00%
Dec 31, 202218-1,160,9881.51%715.20%950.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr24.43K0.75%-
Fidelity Extended Market Index17.24K0.53%2.70K
Fidelity Series Total Market Index1.26K0.04%-
NT Ext Equity Mkt Idx Fd - L1.05K0.03%-
Northern Trust Extended Eq Market Idx1.05K0.03%-
Fidelity Nasdaq Composite Index553.000.02%-
State St US Extended Mkt Indx NL Cl C535.000.02%-
SSgA U.S. Extended Market Index Class I10.70K0.02%-
Fidelity Total Market Index441.000.01%-
NT Ext Equity Mkt Idx Fd - NL312.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 07, 2024Young David Pres. Research & DevelopmentBuy$51.53K
Feb 06, 2024Young David Pres. Research & DevelopmentBuy$50.50K
Feb 01, 2024Lin Patrick Chief Business - Strategy OffBuy$3.60K
Jan 31, 2024Lin Patrick Chief Business - Strategy OffBuy$5.92K
Jan 30, 2024Ng George K Chief Executive OfficerBuy$27.00K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q16-
2023 Q4--
2023 Q3--
2023 Q25-

PCSA Ownership FAQ

Who Owns Processa Pharmaceuticals?

Processa Pharmaceuticals shareholders are primarily institutional investors at 4.19%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Processa Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Processa Pharmaceuticals falls below.

Does Blackrock own Processa Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Processa Pharmaceuticals.

Who is the top mutual fund holder of Processa Pharmaceuticals shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Processa Pharmaceuticals shares, with 0.75% of its total shares outstanding invested in 24.43K Processa Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools